Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

NCT07154043
completednot_applicable

Underwater Galvanic Stimulation by 4-Cell Bath on Lymphedema.

NCT06753175
completednot_applicable

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

NCT03762044
unknownnot_applicable

Lymphedema Treatment for Blunt Facial Trauma

NCT02977182

Clinical Trials (4)

Showing 4 of 4 trials
NCT07154043Not Applicable

Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

Recruiting
NCT06753175Not Applicable

Underwater Galvanic Stimulation by 4-Cell Bath on Lymphedema.

Completed
NCT03762044Not Applicable

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

Completed
NCT02977182Not Applicable

Lymphedema Treatment for Blunt Facial Trauma

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4